Insider · CIK 0001793252
Jerzy Gumulka
Files at CNSP (CNS Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Jerzy Gumulka files SEC Form 4 as director at CNSP (CNS Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jerzy Gumulka has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | CNSP CNS Pharmaceuticals, Inc. | AGrant or award Option to purchase common stockderivative | +1,517 | $0.00 | $0 | 1,517 | Nov 19, 2025 |
Questions about Jerzy Gumulka
Answered from the filings on this page, as of the latest one.
Is Jerzy Gumulka buying or selling?
Jerzy Gumulka has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jerzy Gumulka's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jerzy Gumulka has 0.
Where does Jerzy Gumulka file Form 4?
Jerzy Gumulka has filed Form 4 at CNSP (CNS Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.